DeepMed Research

UNIVERSITY OF LIVERPOOL

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: -

Established: 1903-01-01

Employees: -

Market Cap: -

Website: https://liverpool.ac.uk/

Clinical Trials

Dose Response Study of Nitisinone in Alkaptonuria

Phase 2

Completed

Conditions: Alkaptonuria

Interventions: Drug: Nitisinone

First Posted Date: 2013-04-10

Last Posted Date: 2014-06-11

Lead Sponsor: University of Liverpool

Target Recruit Count: 40

Registration Number: NCT01828463

Locations: 🇬🇧
Royal Liverpool Hospital, Liverpool, Merseyside, United Kingdom

Comparison of Two Dental Techniques Used to Treat Teeth Which Have Become Infected or Painful Following Trauma

Phase 4

Completed

Conditions: Apexogenesis
Pulp Necrosis
Periapical Periodontitis
MTA
Pulp Revascularisation
Apexification
Non-vital Immature Tooth

Interventions: Procedure: Mineral trioxide aggregate
Procedure: Revascularisation

First Posted Date: 2013-03-25

Last Posted Date: 2015-12-10

Lead Sponsor: University of Liverpool

Target Recruit Count: 30

Registration Number: NCT01817413

Locations: 🇬🇧
University of Liverpool, Liverpool, United Kingdom

De- Escalation and Stopping Treatment of Imatinib, Nilotinib or sprYcel in Chronic Myeloid Leukaemia

Phase 2

Completed

Conditions: Chronic Myeloid Leukaemia

Interventions: Drug: Imatinib
Drug: nilotinib
Drug: dasatinib

First Posted Date: 2013-03-05

Last Posted Date: 2025-03-14

Lead Sponsor: University of Liverpool

Target Recruit Count: 174

Registration Number: NCT01804985

Locations: 🇬🇧
University of Liveprool, Liverpool, United Kingdom

Induction With Foley OR Misoprostol (INFORM) Study

Phase 3

Completed

Conditions: Fetus or Newborn; Effects of Induction of Labor
Pre-eclampsia

Interventions: Device: Foley Catheter
Drug: Misoprostol

First Posted Date: 2013-02-28

Last Posted Date: 2015-12-14

Lead Sponsor: University of Liverpool

Target Recruit Count: 602

Registration Number: NCT01801410

Locations: 🇮🇳
Government Medical College (GMC), Nagpur, India
🇮🇳
Daga Memorial Women's Hospital, Nagpur, Maharashtra, India

A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment

Phase 3

Conditions: Chronic Lymphocytic Leukaemia

Interventions: Drug: Ofatumumab
Drug: Bendamustine
Drug: Chlorambucil

First Posted Date: 2012-09-05

Last Posted Date: 2012-10-15

Lead Sponsor: University of Liverpool

Target Recruit Count: 670

Registration Number: NCT01678430

Locations: 🇬🇧
Derriford Hospital, Plymouth, Devon, United Kingdom
🇬🇧
Torbay Hospital, Torquay, Devon, United Kingdom
🇬🇧
Dorset County Hospital, Dorchester, Dorset, United Kingdom

and more 23 locations

Clinical Trial Comparing Gemcitabine and Vandetanib Therapy with Gemcitabine Alone in Pancreatic Carcinoma

Phase 2

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: Placebo
Drug: Caprelsa (vandetanib)

First Posted Date: 2012-05-18

Last Posted Date: 2025-03-13

Lead Sponsor: University of Liverpool

Target Recruit Count: 142

Registration Number: NCT01601808

Locations: 🇬🇧
Belfast City Hospital, Belfast, United Kingdom
🇬🇧
The Royal Bournemouth Hospital, Bournemouth, United Kingdom
🇬🇧
Bristol Haematology and Oncology Centre, Bristol, United Kingdom

and more 11 locations

Safety Study of Recombinant Listeria Monocytogenes(Lm)Based Vaccine Virus Vaccine to Treat Oropharyngeal Cancer

Phase 1

Terminated

Conditions: HPV-16 +ve Oropharyngeal Carcinoma

First Posted Date: 2012-05-15

Last Posted Date: 2016-05-18

Lead Sponsor: University of Liverpool

Target Recruit Count: 2

Registration Number: NCT01598792

Locations: 🇬🇧
Velindre NHS Trust, Cardiff, United Kingdom
🇬🇧
The Royal Liverpool and Broadgreen University Hospitals NHS Foundation Trust, Liverpool, United Kingdom
🇬🇧
Aintree University NHS Foundation Trust, Liverpool, United Kingdom

and more 1 locations

A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients

Phase 3

Completed

Conditions: Follicular Lymphoma

Interventions: Drug: Rituximab
Drug: Cyclophosphamide
Drug: Fludarabine
Drug: Vincristine
Drug: Prednisolone

First Posted Date: 2011-02-25

Last Posted Date: 2025-04-18

Lead Sponsor: University of Liverpool

Target Recruit Count: 680

Registration Number: NCT01303887

Locations: 🇬🇧
Ysbyty Gwynedd, Bangor, United Kingdom
🇬🇧
Birmingham Heartlands, Birmingham, United Kingdom
🇬🇧
Luton & Dunstable Hospital, Luton, United Kingdom

and more 70 locations

Plerixafor Harvesting and No Chemotherapy for Transplantation of Autologous STem Cells in Cancer (PHANTASTIC)

Not Applicable

Completed

Conditions: Multiple Myeloma
Plasma Cell Dyscrasia
Lymphoma
Lymphoproliferative Disorders

Interventions: Drug: Plerixafor and G-CSF

First Posted Date: 2010-08-23

Last Posted Date: 2025-03-17

Lead Sponsor: University of Liverpool

Target Recruit Count: 60

Registration Number: NCT01186224

Locations: 🇬🇧
Dept of Haematology, University of Liverpool, Liverpool, Merseyside, United Kingdom

Intensive Care Unit (ICU) Diaries as a Therapeutic Intervention for Post Traumatic Stress Disorder (PTSD) Following Critical Illness

Not Applicable

Completed

Conditions: Post-Traumatic Stress Disorder

Interventions: Other: ICU Diary

First Posted Date: 2009-06-03

Last Posted Date: 2009-06-03

Lead Sponsor: University of Liverpool

Target Recruit Count: 352

Registration Number: NCT00912613

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy